We are live on ! Find out more
FBC

Fairfield, Bush & Co Portfolio holdings

AUM $180M
1-Year Est. Return 39.51%
This Fund
S&P 500
This Quarter Est. Return
+12.12%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$171M
AUM Growth
+$17.5M
Cap. Flow
+$1.12M
Cap. Flow %
0.66%
Top 10 Hldgs %
36.71%
Holding
532
New
422
Increased
22
Reduced
72
Closed
2

Sector Composition

Rank Sector Weight
1 Technology 30.84%
2 Healthcare 14.53%
3 Consumer Staples 13.76%
4 Financials 8.41%
5 Consumer Discretionary 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RF icon
426
Regions Financial
RF
$27.2B
$1.16K ﹤0.01%
+60
New +$996
ZIMV
427
DELISTED
ZimVie
ZIMV
$1.15K ﹤0.01%
+65
New +$655
MAS icon
428
Masco
MAS
$15B
$1.14K ﹤0.01%
+17
New +$987
CCCC icon
429
C4 Therapeutics
CCCC
$391M
$1.13K ﹤0.01%
+200
New +$456
JEPI icon
430
JPMorgan Equity Premium Income ETF
JEPI
$45.7B
$1.1K ﹤0.01%
+20
New +$1.08K
SPSM icon
431
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.5B
$1.1K ﹤0.01%
+26
New +$980
BBY icon
432
Best Buy
BBY
$17.8B
$1.1K ﹤0.01%
+14
New +$986
ABNB icon
433
Airbnb
ABNB
$88.7B
$1.09K ﹤0.01%
+8
New +$1.03K
ARTY
434
iShares Future AI & Tech ETF
ARTY
$3.79B
$1.03K ﹤0.01%
+30
New +$950
IJS icon
435
iShares S&P Small-Cap 600 Value ETF
IJS
$8.35B
$1.03K ﹤0.01%
+10
New +$911
OPCH icon
436
Option Care Health
OPCH
$3.5B
$1.01K ﹤0.01%
+30
New +$922
IOVA icon
437
Iovance Biotherapeutics
IOVA
$1.96B
$976 ﹤0.01%
+120
New +$628
GMAB icon
438
Genmab
GMAB
$17.8B
$955 ﹤0.01%
+30
New +$942
GGG icon
439
Graco
GGG
$13.2B
$954 ﹤0.01%
+11
New +$865
CHX
440
DELISTED
ChampionX
CHX
$935 ﹤0.01%
+32
New +$990
CLPT icon
441
ClearPoint Neuro
CLPT
$376M
$910 ﹤0.01%
+134
New +$759
QRVO icon
442
Qorvo
QRVO
$8.25B
$901 ﹤0.01%
+8
New +$772
LII icon
443
Lennox International
LII
$15.2B
$895 ﹤0.01%
+2
New +$798
NOK icon
444
Nokia
NOK
$54.8B
$895 ﹤0.01%
+262
New +$890
INCY icon
445
Incyte
INCY
$24.1B
$879 ﹤0.01%
+14
New +$792
PTC icon
446
PTC
PTC
$15.3B
$875 ﹤0.01%
+5
New +$767
BSX icon
447
Boston Scientific
BSX
$70.4B
$867 ﹤0.01%
+15
New +$801
JCI icon
448
Johnson Controls International
JCI
$91.4B
$865 ﹤0.01%
+15
New +$787
LUCK
449
Lucky Strike Entertainment
LUCK
$908M
$864 ﹤0.01%
+61
New +$670
CFG icon
450
Citizens Financial Group
CFG
$31.1B
$862 ﹤0.01%
+26
New +$716

Similar funds

Fairfield, Bush & Co's Q4 2023 Portfolio in Review

As of Q4 2023, Fairfield, Bush & Co held 532 positions worth $171M, up 11% from $153M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Fairfield, Bush & Co's Q4 2023 filing shows 422 new, 22 increased, 72 reduced and 2 closed positions. Its largest new stake was iShares Russell 2000 ETF: 3,027 shares worth $608K. The largest sale was Seagen Inc. Common Stock, an estimated $1.35M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Fairfield, Bush & Co's largest Q4 2023 buy was iShares Russell 2000 ETF: 3,027 shares worth $608K.
  • Fairfield, Bush & Co added most to Novo Nordisk in Q4 2023, an estimated $822K increase.
  • Fairfield, Bush & Co's biggest Q4 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $1.35M.
  • Fairfield, Bush & Co fully exited Activision Blizzard in Q4 2023, selling an estimated $810K.
  • Fairfield, Bush & Co's ten largest holdings make up 37% of its $171M portfolio in Q4 2023.
  • Fairfield, Bush & Co opened 422 new positions and closed 2 in Q4 2023.
  • Fairfield, Bush & Co's portfolio value rose 11% quarter-over-quarter to $171M.

Based on Fairfield, Bush & Co's 13F filing for Q4 2023, filed 13 Feb 2024.